Stevanato Group (STVN)
(Delayed Data from NYSE)
$25.58 USD
+0.46 (1.83%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $25.56 -0.02 (-0.08%) 7:22 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Stevanato Group S.p.A. has a PEG ratio of 2.65 compared to the Medical - Drugs industry's PEG ratio of 1.26.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
STVN 25.58 +0.46(1.83%)
Will STVN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STVN
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?
MKKGY or STVN: Which Is the Better Value Stock Right Now?
STVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
Will Escalating Medical Costs Dampen Centene's Q2 Earnings?
CPRX or STVN: Which Is the Better Value Stock Right Now?
Other News for STVN
Stevanato Group Reaches Analyst Target Price
Conestoga Small Cap Composite Q2 2025 Commentary
Stevanato secures €200M in financing